PAREXEL Strengthens Commitment to Global Biopharmaceutical Workforce with New PAREXEL Academy Programs

April 13, 2015
Company Press Release

Applied Clinical Trials

BOSTON, April 8, 2015 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic programs at the PAREXEL Academy. The offerings span the globe and are designed to prepare students for careers in the biopharmaceutical industry:

Bachelor of Science Degree in Clinical Research – Offered in partnership with the Medical School Berlin, in Berlin, Germany, the degree program features courses specific to clinical research. Courses range from ethics in health and medicine to conducting clinical trials. Several courses are taught by PAREXEL experts.

Postgraduate Certificate in Clinical Trial Management – In cooperation with Salem State University in Salem, Massachusetts, the postgraduate certificate program features a broad-based curriculum in various components of the full life cycle of drug development.

Joint Program for Clinical Research and Clinical Trial Management – In collaboration with Kyoto Pharmaceutical University in Kyoto, Japan, the joint program provides fifth grade undergraduate students an introductory, seven-week course in clinical research and clinical trial management.

“PAREXEL is committed to developing the biopharmaceutical industry’s next-generation global workforce,” said Heidrun Bruchmann, Ph.D., Senior Director, PAREXEL Academy. “Through the PAREXEL Academy, we tailor educational and degree programs with our partners to equip the future health sciences workforce with a holistic and cross-functional foundation in clinical research and clinical trial management.”

For more than a decade, the PAREXEL Academy has designed and implemented a wide range of learning programs tailored to enable clinical research management practices for learners inside and outside of PAREXEL. The PAREXEL Academy has locations in the United States, Europe, and Asia. Since inception, approximately 1,000 students have graduated from the Academy’s programs, including its undergraduate Bachelor of Science program.

Mary L. Churchill, Ph.D. Associate Provost, Innovation and Partnerships, Salem State University, commented that “Salem State is committed to providing students with programs that are both foundational and workforce-aligned. Through our partnership with the PAREXEL Academy, we create programs to give students the specific tools needed to succeed post-graduation in biopharmaceutical research.”